Bernstein Upgrades Biogen to Outperform, Announces $500 Price Target
Bernstein analyst Aaron Gal upgrades Biogen (NASDAQ:BIIB) from Market Perform to Outperform and announces $500 price target.
Goldman Sachs Upgrades Canadian Natural Res to Buy, Raises Price Target to $44
Goldman Sachs analyst Neil Mehta upgrades Canadian Natural Res (NYSE:CNQ) from Neutral to Buy and raises the price target from $38 to $44.
Wells Fargo Upgrades Signet Jewelers to Equal-Weight, Raises Price Target to $70
Wells Fargo analyst Ike Boruchow upgrades Signet Jewelers (NYSE:SIG) from Underweight to Equal-Weight and raises the price target from $57 to $70.
JPMorgan Upgrades UPS After Recent Sell-Off
United Parcel Service, Inc.’s (NYSE: UPS) 2021 Investor Day provided positive views on pricing power, capacity discipline and dividend yield, according to JPMorgan.
RBC Capital Upgrades Range Resources to Outperform, Raises Price Target to $20
RBC Capital analyst Scott Hanold upgrades Range Resources (NYSE:RRC) from Sector Perform to Outperform and raises the price target from $15 to $20.
UBS Upgrades Biogen to Buy, Announces $463 Price Target
UBS analyst Colin Bristow upgrades Biogen (NASDAQ:BIIB) from Neutral to Buy and announces $463 price target.
Gordon Haskett Upgrades RH to Accumulate, Raises Price Target to $750
Gordon Haskett analyst Chuck Grom upgrades RH (NYSE:RH) from Hold to Accumulate and raises the price target from $550 to $750.
B of A Securities Upgrades Sea to Buy, Raises Price Target to $340
B of A Securities analyst Paul Dewberry upgrades Sea (NYSE:SE) from Neutral to Buy and raises the price target from $260 to $340.
Truist Securities Upgrades Mid-America Apartment to Buy, Raises Price Target to $178
Truist Securities analyst Michael Lewis upgrades Mid-America Apartment (NYSE:MAA) from Hold to Buy and raises the price target from $151 to $178.